Cargando…

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) patients have low activity. Activity intensity or duration could be a measure of clinical status or improvement. We aimed to determine whether standard or novel actigraphy measures could detect increases in activity after adding therapy. This was a prospective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachant, Daniel, Light, Allison, Lachant, Michael, Annis, Jeffrey, Hemnes, Anna, Brittain, Evan, James White, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493080/ https://www.ncbi.nlm.nih.gov/pubmed/37701142 http://dx.doi.org/10.1002/pul2.12285

Ejemplares similares

Comparison of chest- and wrist-based actigraphy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2021)

Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
por: Lachant, Daniel, et al.
Publicado: (2022)

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
por: Arevalo, Carlo, et al.
Publicado: (2022)

Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre‐ and postcapillary pulmonary hypertension
por: Babu, Gautam, et al.
Publicado: (2023)

An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record
por: Schuler, Kyle P., et al.
Publicado: (2022)

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli
por: Lachant, Daniel J., et al.
Publicado: (2021)

Heart rate monitoring improves clinical assessment during 6-min walk
por: Lachant, Daniel J., et al.
Publicado: (2020)

Reduced free-living activity levels in pulmonary arterial hypertension patients
por: Halliday, Stephen J., et al.
Publicado: (2018)

Chronic thromboembolic pulmonary hypertension is a clot you cannot swat
por: Bishop, G. Jay, et al.
Publicado: (2019)

Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus
por: Lachant, Daniel, et al.
Publicado: (2020)

Shuttling toward Improved Clinic-based Assessment of Exercise Capacity in Pulmonary Arterial Hypertension
por: Brittain, Evan L.
Publicado: (2021)

Heart Rate Expenditure Correlates with Right Ventricular Function
por: Lachant, Daniel J., et al.
Publicado: (2020)

Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza()
por: Lachant, Daniel, et al.
Publicado: (2021)

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
por: Lachant, Daniel J., et al.
Publicado: (2020)

Ferroptosis Promotes Pulmonary Hypertension
por: Vogel, Neal T., et al.
Publicado: (2023)

Hemodynamic Improvement of Pulmonary Arterial Hypertension After Bariatric Surgery: Potential Role for Metabolic Regulation
por: Pugh, Meredith E., et al.
Publicado: (2013)

Meningococcemia Presenting as a Myocardial Infarction
por: Lachant, Daniel, et al.
Publicado: (2015)

Legionella micdadei: A Forgotten Etiology of Growing Cavitary Nodules: A Case Report and Literature Review
por: Lachant, Daniel, et al.
Publicado: (2015)

Glyoxylase-1 combats dicarbonyl stress and right ventricular dysfunction in rodent pulmonary arterial hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2022)

Identifying “super responders” in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2017)

CMV Encephalitis/Radiculitis: The Difficulty in Diagnosing in an Intubated Patient
por: Newcomb, Geoffrey, et al.
Publicado: (2019)

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
por: Baah, Samantha, et al.
Publicado: (2021)

Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case–control study
por: Badlam, Jessica B., et al.
Publicado: (2020)

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
por: Hemnes, Anna R., et al.
Publicado: (2017)

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2018)

Predictors of Diastolic-To-Wedge Gradient in Patients Evaluated for Pulmonary Hypertension
por: Brittain, Evan L., et al.
Publicado: (2013)

The molecular targets of approved treatments for pulmonary arterial hypertension
por: Humbert, Marc, et al.
Publicado: (2016)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
por: Lachant, Daniel J., et al.
Publicado: (2013)

A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific
por: Talati, Megha, et al.
Publicado: (2023)

Cardiometabolic Risk Factors Associated With Right Ventricular Function and Compensation in Patients Referred for Echocardiography
por: Morrison, Amanda M., et al.
Publicado: (2023)

Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial Hypertension
por: Brittain, Evan L., et al.
Publicado: (2020)

Lack of a Tricuspid Regurgitation Doppler Signal and Pulmonary Hypertension by Invasive Measurement
por: O'Leary, Jared M., et al.
Publicado: (2018)

Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms
por: Meegan, Jamie E., et al.
Publicado: (2023)

The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension
por: Meoli, David F., et al.
Publicado: (2017)

Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency
por: Huston, Jessica, et al.
Publicado: (2020)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
por: Caccamo, Marco, et al.
Publicado: (2023)

Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes
por: O’Leary, Jared M., et al.
Publicado: (2017)

CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
por: Agrawal, Vineet, et al.
Publicado: (2019)

Acute limb ischemia and aortic mural thrombosis as primary manifestations of severe acute respiratory syndrome coronavirus 2
por: Szeles, Andras, et al.
Publicado: (2021)

Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension
por: Hemnes, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e38t71viilgh306i8i5oik7a1e